CYCLERION THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards
CYCLERION THERAPEUTICS, INC. (CYCN) had Deferred Tax Assets, Operating Loss Carryforwards of $57.62 million as of 2025-12-31, per its S-4/A filed 2026-07-22.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-07-22
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $57.62M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $53.28M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $48.53M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $47.08M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $57.62M S-4/A · filed 2026-07-22 |
| 2024-12-31 | $53.28M S-4/A · filed 2026-07-22 |
| 2023-12-31 | $48.53M 10-K/A · filed 2025-11-12 |
| 2022-12-31 | $47.08M 10-K · filed 2024-03-05 |
| 2021-12-31 | $43.70M 10-K · filed 2023-03-22 |
| 2020-12-31 | $27.01M 10-K · filed 2022-02-24 |
| 2019-12-31 | $17.23M 10-K · filed 2021-02-25 |
| 2018-12-31 | $97.05M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |